Health & Biotech
Check out the latest COVID-19 and Coronavirus news, insights and unique analysis brought to you by Stockhead’s team of business journalists and industry experts.
Health & Biotech
MGC Pharma makes inroads in the fight against COVID-19, getting a regulatory nod in Germany and a successful trial in India
Tech
ClariqAIR is convinced that the next round will be on them
Experts
MoneyTalks: AMP Capital’s Dermot Ryan on why it’s a good time for forward-looking income investing
Stockhead TV
Gold: Price forecast, Delta impact and Evolution Mining’s recent successes
News
These are the ASX stocks that could benefit from post-COVID mobility trends
News
Stake data shows Aussie investors have taken an interest in global COVID-19 vaccine stocks
Stockhead TV
Market Movers: Oriel Morrison interviews Peter Malone, exec chair of Skin Elements Ltd (ASX:SKN)
Health & Biotech
MGC Pharma’s lead product CimetrA one step closer to a registered medicine for COVID-19 patients in India
Health & Biotech
Good timing, and flexible funding: Why Dimerix’s $20m share placement is ‘transformational’ for the business, with CEO Nina Webster
Health & Biotech
Skin Elements flags commercialisation plans for its COVID-19 disinfectant spray after securing key TGA approval
Health & Biotech
Neuroscientific Biopharmaceuticals says EmtinB shows promise as a multiple sclerosis treatment
Health & Biotech
Dimerix shares up 8% on DMX-200 FSGS Phase 3 trial news
News
Reporting Season Round Up: Kogan surpasses $1 billion in revenue but shares dive on profit fall
News
This ASX-listed real estate investor is the latest stock to invest in the hotels space
News
Australian financial services market grew 13pc in FY21, but who were the biggest beneficiaries?
Health & Biotech
Dimerix shares surge after company secures ‘transformational’ $20m funding round from major investors
Health & Biotech
Dimerix’s flags acceleration of Phase 3 trials for its COVID-19 treatment in Europe
Health & Biotech
Dimerix rounds out Q4 with a multi-channel product suite and key support from global regulators as clinical trials progress
Health & Biotech
PharmAust’s pill significantly protects against COVID-19 virus
Tech
Sydney’s Aiden Hotel to install ClariqAir’s hydroxyl technology to combat spread of coronavirus
Health & Biotech
Investors have struggled to find long term money makers from COVID, but has this sector been the one all along?
Health & Biotech
Atomo Diagnostics shares surge after COVID test is authorised by the FDA
News
Here’s how we should pick stocks after the ‘tick-like’ COVID recovery, according to two money managers
Tech
ClariqAir patented technology set to lead the booming air purifier market as it eyes ASX listing
Experts
MoneyTalks: Investors are uncertain about sustainable earnings, but this fundie thinks these companies are solid
Health & Biotech
MGC Pharma announces exciting new developments in the fight against COVID-19
Health & Biotech
Dr Boreham’s Crucible: Has Anteotech got Covid tests down to an ART form?
Health & Biotech
How Dimerix is now playing a crucial role in the global fight against COVID-19
News
WFH is here to stay. But which ASX stocks will stay to benefit?
Health & Biotech
Awareness of the Pfizer vaccine in Australia could unlock a new health investment trend, says one VC
News
Oil will surge 19pc and copper will see double-digit returns over the next 6 months, Goldman says
Health & Biotech
Here’s why the COVID-induced telehealth boom is only just beginning
Health & Biotech
COVID-19 study using Dimerix drug compound recruits patients in Europe
IPO Watch
IPO Watch: $2.6b lender Latitude Financial lists on the ASX; gains another 15pc on debut
News
Hong Kong domiciled penny stock Merchant House nearly triples after US$20m factory sale
Health & Biotech
Skin Elements to launch its ‘game-changing’ COVID-19 spray Invisi Shield, after signing off a new $20 million equity facility
News
ASX investors are increasingly relying on each other for financial advice
News
A wave of corporate insolvencies might be coming; but it could be good news for these ASX stocks
Health & Biotech
AstraZeneca rollout in jeopardy? The ASX’s COVID vaccine maker and wannabe seem immune
News
Jayride rockets by 76 per cent, as ASX travel stocks rise on travel bubbles
News
As people return to the office, these are the ASX shares set to benefit
News
Cleanspace halves after revealing a drop in North American sales
Experts
MoneyTalks: Which ASX retail stocks are safe from Amazon and which ones are vulnerable?
Tech
Telehealth Oneview rises by 400pc in two weeks; how will other ASX wellness stocks play out post-COVID?
Health & Biotech
Stock of the day: Nanoveu goes truly global after coffee deal with Nestle, share price shoots 90pc
News
These ASX small caps are rated by IBISWorld among Australia’s top 1000 companies
News
There’s only one ASX stock involved in the COVID vaccine rollout right now; and it’s just dispatched the first doses
Load More
